Security key
03528H109
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 35,258,614
- Total 13F shares
- 1,226,425
- Share change
- -23,971
- Total reported value
- $4,448,000
- Price per share
- $3.63
- Number of holders
- 13
- Value change
- -$180,456
- Number of buys
- 7
- Number of sells
- 4
Report period
Q2 2019
Institutions
13
Top holders
10
ANIX full security history
Newer quarter: Q3 2019
Previous quarter: Q1 2019
Anixa Biosciences Inc SEC filings
Anixa Biosciences Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03528H109
Recent filing periods:
Top shareholders of ANIX - Anixa Biosciences Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
641,473
|
$2,900,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0.59%
|
206,743
|
$934,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
102,487
|
$463,000 | — | 31 Mar 2019 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.29%
|
101,616
|
$459,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
58,993
|
$267,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.14%
|
49,851
|
$225,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
39,807
|
$180,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
17,712
|
$80,000 | — | 31 Mar 2019 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.05%
|
17,400
|
$79,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
6,970
|
$32,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
4,088
|
$18,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
2,846
|
$13,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
999
|
$5,000 | — | 31 Mar 2019 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
410
|
$2,000 | — | 31 Mar 2019 |
Institutional Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q2 2019
As of 30 Jun 2019,
Anixa Biosciences Inc - Common Stock (ANIX) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,226,425 shares.
The largest 10 holders included
VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., NORTHERN TRUST CORP, Bank of New York Mellon Corp, SEGALL BRYANT & HAMILL, LLC, MORGAN STANLEY, RAYMOND JAMES & ASSOCIATES, and JPMORGAN CHASE & CO.
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
14
Q2 2019 holders
13
Holder diff
-1
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.